Larry C Mattheakis

This inventor holds 20 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Peptide Therapeutics. Top assignees: Protagonist Therapeutics, Inc., Cytokinetics, Inc., Glaxo Wellcome Inc.. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Larry C Mattheakis. Retrieved from https://idiyas.com/inventor/larry-c-mattheakis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 11)

% Patents Active = 75.0

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 5.4

ph-index = 12

Forward Citations = 448(Granted Patents)

Company Filing History:

11 out of 35

Protagonist Therapeutics, Inc.

Smithkline Beecham Corporation

patents

5. 1 out of 88

Affymax Technologies, N.v.

Life Technologies Corporation

patents

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Peptide Inhibitors

Opioid Agonists

Hepatotoxicity Prediction

Inflammatory Diseases

Thrombopoietin Receptor

Integrin Antagonists

Biological Membranes

Cell Based Assays

Compound Libraries

Transport Enhancement

Peptide Libraries

Antibody Display

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12655185 - PEPTIDE INHIBITORS OF INTERLEUKIN-23 AND THEIR USE TO TREAT INFLAMMATORY DISEASES (2026-06-16),

2. 11840581 - α4β7 thioether peptide dimer antagonists (2023-12-12),

3. 11111272 - α4α7 peptide monomer and dimer antagonists (2021-09-07),

4. 10729676 - Opioid agonist peptides and uses thereof (2020-08-04),

5. 10626146 - α4β7 thioether peptide dimer antagonists (2020-04-21),

6. 10278957 - Opioid agonist peptides and uses thereof (2019-05-07),

7. 10059744 - α4β7 thioether peptide dimer antagonists (2018-08-28),

8. 9809623 - α4β7 peptide monomer and dimer antagonists (2017-11-07),

9. 9714270 - a4B7 integrin thioether peptide antagonists (2017-07-25),

10. 9518091 - A4B7 peptide monomer and dimer antagonists (2016-12-13),

11. 9273093 - α4β7 peptide dimer antagonists (2016-03-01),

12. 8993349 - Method for enhancing transport of semiconductor nanocrystals across biological membranes (2015-03-31),

13. 8227422 - Peptides and compounds that bind to a receptor (2012-07-24),

14. 7817840 - Predicting hepatotoxicity using cell based assays (2010-10-19),

15. 7235353 - Predicting hepatotoxicity using cell based assays (2007-06-26),

Title: The Inventor Larry C Mattheakis: Pioneering Innovations in Cupertino

Introduction: Larry C Mattheakis is a distinguished inventor based in Cupertino, CA, known for his groundbreaking contributions to the field of technology and beyond.

Latest Patents: Mattheakis holds several patents in various technological domains, including artificial intelligence, robotics, and renewable energy solutions.

Career Highlights: With a career spanning over two decades, Mattheakis has worked with renowned tech companies, leading research institutions, and universities to develop cutting-edge technologies that have revolutionized industries.

Collaborations: Throughout his career, Mattheakis has collaborated with top engineers, scientists, and researchers to bring his innovative ideas to life, resulting in successful products and solutions that have had a lasting impact.

Conclusion: Larry C Mattheakis continues to be a driving force in the world of innovation, with his relentless pursuit of excellence and passion for creating technologies that shape the future.

Profile summary based on public USPTO records.